Irinotecan plus temozolomide for relapsed or refractory neuroblastoma Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Neoplasm Recurrence, Local
  • Neuroblastoma

abstract

  • This regimen has anti-NB activity, spares vital organs, is feasible with poor bone marrow reserve, causes limited immunosuppression, and allows good quality of life.

publication date

  • November 20, 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2006.06.7272

PubMed ID

  • 17114661

Additional Document Info

start page

  • 5271

end page

  • 6

volume

  • 24

number

  • 33